IRON (Disc Medicine) Short Interest


IRON Disc Medicine Inc IRON
34 GF Score
Price $70.08
! 3 Warning Signs
View Full Analysis

What is Disc Medicine Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

IRON vs DFTX, ARQT, MLYS: Short Interest Comparison

For the Biotechnology subindustry, Disc Medicine's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Disc Medicine Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Disc Medicine's Short Interest distribution charts can be found below:

* The bar in red indicates where Disc Medicine's Short Interest falls into.


IRON
34GF Score
Disc Medicine Inc IRON
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disc Medicine Business Description

Address 321 Arsenal Street, Suite 101, Watertown, MA, USA, 02472
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
34GF Score

Get the complete analysis for IRON

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$70.08
Price